Restore your bodys natural resilience
Dispose of materials in accordance with institutional guidelines for chemical and peptide waste
While not yet FDA-approved as a standalone agent, cagrilintide peptide therapy is being investigated for: Obesity treatment Metabolic syndrome management Adjunctive therapy for GLP-1 agonist non-responders Research in combination with emerging agents like retatrutide Note: As of 2025, cagrilintide is still considered a research compound in many jurisdictions
Wondering how to get the most from your dose of B12/MIC
Building your personalised GHK-Cu protocol in Mumbai A workable GHK-Cu protocol comes from six clean steps: Define the goal - skin, hair, healing, longevity or a combination Choose the route - injectable, topical, oral, or a combination Set the starting dose - conservative end of the range for your goal Set the schedule - daily, 5-on/2-off, or 3/week